학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 1,757건 | 목록 1~20
Academic Journal
Mosquera Orgueira A; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.; Gonzalez Perez MS; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.; D'Agostino M; Division of Hematology, AOU Città della Salute e della Scienza di Torino University of Torino Torino Italy.; Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy.; Cairns DA; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research University of Leeds Leeds United Kingdom.; Larocca A; Department of Molecular Biotechnology and Health Sciences, Division of Hematology University of Torino Torino Italy.; Palacios JJL; Hospital Universitario 12 de Octubre CIBER-ONC CB16/12/00369, CNIO Madrid Spain.; Wester R; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.; Bertsch U; National Center for Tumor Diseases Heidelberg Heidelberg Germany.; Department of Medicine V, Heidelberg Myeloma Center University Hospital Heidelberg Heidelberg Germany.; Waage A; Institute of Clinical and Molecular Medicine Norwegian University of Science and Technology and St. Olavs Hospital Trondheim Norway.; Zamagni E; Department of Medical and Surgical Sciences, 'Seràgnoli' Institute of Hematology University of Bologna Bologna Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy.; Pérez Míguez C; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.; Rojas Martínez JA; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.; Mai EK; Department of Internal Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg GMMG Study Group Heidelberg Germany.; Crucitti D; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.; Salwender H; Asklepios Tumorzentrum Hamburg Asklepios Hospital Hamburg Altona and St. Georg Hamburg Germany.; Dall'Olio D; Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy.; Castellani G; Department of Medical and Surgical Sciences (DIMEC) University of Bologna Bologna Italy.; Piñeiro Fiel M; Department of Hematology, IDIS University Hospital of Santiago de Compostela Santiago de Compostela Spain.; Bringhen S; AOU Città della Salute e della Scienza di Torino Torino Italy.; Zweegman S; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam Vrije Universiteit Amsterdam Amsterdam The Netherlands.; Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna Institute of Hematology 'L. e A. Seràgnoli' Bologna Italy.; Department of Medical and Surgical Sciences University of Bologna Bologna Italy.; Iqbal S; Medical Information Scientific Engagement Johnson & Johnson Innovative Medicines New York New York United States.; Hernandez Rivas JM; Department of Medicine, Cancer Research Center (IBMCC, USAL-CSIC), Institute of Biomedical Research of Salamanca (IBSAL) University of Salamanca Salamanca Spain.; Bruno B; Division of Hematology, AOU Città della Salute e della Scienza di Torino University of Torino Torino Italy.; Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy.; Cook G; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research University of Leeds Leeds United Kingdom.; Kaiser MF; Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research University of Leeds Leeds United Kingdom.; The Institute of Cancer Research and the Royal Marsden Hospital London United Kingdom.; Goldschmidt H; National Center for Tumor Diseases Heidelberg Heidelberg Germany.; Department of Medicine V, Heidelberg Myeloma Center University Hospital Heidelberg Heidelberg Germany.; Van De Donk NWCJ; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam Vrije Universiteit Amsterdam Amsterdam The Netherlands.; Jackson G; Department of Haematology Newcastle University Newcastle Upon Tyne United Kingdom.; San-Miguel JF; Clínica Universidad de Navarra CIMA, IDISNA, CIBERONC (CB16/12/00369) Pamplona Spain.; Boccadoro M; European Myeloma Network (EMN) Italy.; Mateos MV; Department of Medicine, Cancer Research Center (IBMCC, USAL-CSIC), Institute of Biomedical Research of Salamanca (IBSAL) University of Salamanca Salamanca Spain.; Sonneveld P; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Gerotziafas G; Sorbonne University, INSERM UMR_S_938, Saint-Antoine Research Center (CRSA), Research Department 'Cancer, Vessels, Biology and Therapeutics' (CaVITE), Research Group 'Cancer-Angiogenesis-Thrombosis and Haemostasis,' Thrombosis Center, University Institute of Cancerology (UIC), Saint Antoine University Hospital Assistance Publique Hôpitaux de Paris (AP-HP) Paris France.; VAS-European Independent Foundation in Angiology/Vascular Medicine Milan Italy.; Fotiou D; Department of Clinical Therapeutics Plasma Cell Dyscrasias Unit, National and Kapodistrian University of Athens, School of Medicine Athens Greece.; Nijhof I; Department of Hematology Amsterdam University Medical Center Amsterdam The Netherlands.; Department of Internal Medicine St. Antonius Hospital Nieuwegein The Netherlands.; Department of Hematology St. Antonius Hospital Nieuwegein The Netherlands.; Ay C; Department of Medicine I, Comprehensive Cancer Center Vienna, Division of Hematology and Hemostaseology Medical University of Vienna Vienna Austria.; Lecumberri R; Hematology Service Clínica Universidad de Navarra Pamplona Spain.; CIBERCV, Carlos III Health Institute Madrid Spain.; Laroca A; Division of Hematology University of Torino, AOU Città della Salute e della Scienza di Torino Torino Italy.; Cook G; Leeds Institute of Clinical Trial Research & Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust Leeds UK.; Engelhardt M; Department of Hematology and Oncology, Interdisciplinary Cancer Center and Comprehensive Cancer Center Freiburg, Faculty of Freiburg University of Freiburg Freiburg Germany.; Zweegman S; Department of Hematology Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands.; Delforge M; Department of Hematology University Hospital Leuven Leuven Belgium.; Maraveyas A; Queen's Centre for Oncology and Haematology, Clinical Sciences Centre, Hull York Medical School and Hull University Teaching Hospitals NHS Trust Hull UK.; Lefkou E; Sorbonne University, INSERM UMR_S_938, Saint-Antoine Research Center (CRSA), Research Department 'Cancer, Vessels, Biology and Therapeutics' (CaVITE), Research Group 'Cancer-Angiogenesis-Thrombosis and Haemostasis,' Thrombosis Center, University Institute of Cancerology (UIC), Saint Antoine University Hospital Assistance Publique Hôpitaux de Paris (AP-HP) Paris France.; VAS-European Independent Foundation in Angiology/Vascular Medicine Milan Italy.; Marchetti M; Department of Immunohematology and Transfusion Medicine Hospital Papa Giovanni XXIII Bergamo Italy.; Department of Medicine and Surgery University of Milano-Bicocca Monza Italy.; Van de Donk NWCJ; Department of Hematology Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands.; Gay F; Division of Hematology University of Torino, AOU Città della Salute e della Scienza di Torino Torino Italy.; Ludwig H; First Department of Medicine Center for Oncology, Hematology, and Palliative Care, Wilhelminen Cancer Research Institute, Clinic Ottakring Vienna Austria.; Einsele H; Department of Internal Medicine II University Hospital Wurzburg Wurzburg Germany.; San Miguel JF; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.; Dimopoulos MA; Department of Clinical Therapeutics Plasma Cell Dyscrasias Unit, National and Kapodistrian University of Athens, School of Medicine Athens Greece.; Department of Medicine Korea University Seoul South Korea.; Boccadoro M; Division of Hematology University of Torino, AOU Città della Salute e della Scienza di Torino Torino Italy.; Sonneveld P; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.; Falanga A; Department of Immunohematology and Transfusion Medicine Hospital Papa Giovanni XXIII Bergamo Italy.; Department of Medicine and Surgery University of Milano-Bicocca Monza Italy.; Terpos E; Department of Clinical Therapeutics Plasma Cell Dyscrasias Unit, National and Kapodistrian University of Athens, School of Medicine Athens Greece.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
van de Donk NWCJ; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands.; Cancer Center Amsterdam Cancer Biology and Immunology Amsterdam The Netherlands.; Moreau P; Department of Hematology University Hospital Hôtel-Dieu Nantes France.; San-Miguel JF; Cancer Center Clinica Universidad de Navarra CIMA, IDISNA, CIBERONC Pamplona Spain.; Mateos MV; Cancer Research Center University Hospital of Salamanca, IBSAL Salamanca Spain.; Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Athens Greece.; Department of Medicine Korea University Seoul South Korea.; Zweegman S; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands.; Cancer Center Amsterdam Cancer Biology and Immunology Amsterdam The Netherlands.; Gay F; University Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy & Department of Biotechnology and Health Sciences University of Torino Italy.; Engelhardt M; Department of Hematology and Oncology, Interdisciplinary Cancer Center and Comprehensive Cancer Center Freiburg University of Freiburg, Faculty of Freiburg Freiburg Germany.; Mina R; University Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy & Department of Biotechnology and Health Sciences University of Torino Italy.; Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia 'Seràgnoli' Bologna Italy.; Dipartimento di Scienze Mediche e Chirurgiche Università di Bologna Bologna Italy.; Delforge M; Department of Hematology University Hospital Leuven Leuven Belgium.; Beksac M; Ankara Liv Hospital Istinye University Ankara Turkey.; Spencer A; Alfred Health-Monash University Melbourne Victoria Australia.; Schjesvold F; Oslo Myeloma Center, Department of Hematology Oslo University Hospital Oslo Norway.; Driessen C; Department of Medical Oncology and Hematology, HOCH Health Ostschweiz Cantonal Hospital St. Gallen St. Gallen Switzerland.; Kaiser M; Department of Hematology, The Royal Marsden Hospital & Division of Genetics and Epidemiology The Institute of Cancer Research London United Kingdom.; Perrot A; Université de Toulouse, Centre Hospital-Universitaire Institut Universitaire du Cancer Toulouse Oncopole Toulouse France.; Wäsch R; Department of Hematology and Oncology, Interdisciplinary Cancer Center and Comprehensive Cancer Center Freiburg University of Freiburg, Faculty of Freiburg Freiburg Germany.; Korst CLBM; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands.; Cancer Center Amsterdam Cancer Biology and Immunology Amsterdam The Netherlands.; Broijl A; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.; Touzeau C; Department of Hematology University Hospital Hôtel-Dieu Nantes France.; Manier S; Department of Hematology Lille University Hospital and INSERM UMR-S1277 and CNRS UMR9020 Lille France.; Hajek R; Department of Hemato-Oncology University Hospital Ostrava Ostrava Czech Republic.; Department of Hemato-Oncology, Faculty of Medicine University of Ostrava Ostrava Czech Republic.; Bila J; Clinic of Hematology, University Clinical Center of Serbia, Medical Faculty University of Belgrade Belgrade Serbia.; Seval GC; Department of Hematology Ankara University Faculty of Medicine Ankara Turkey.; O'Dwyer M; Department of Medicine/Haematology University of Galway Galway Republic of Ireland.; Ludwig H; Wilhelminen Cancer Research Institute, First Department of Medicine Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring Vienna Austria.; Fernandez de Larrea C; Hospital Clínic de Barcelona. IDIBAPS University of Barcelona Barcelona Spain.; Popat R; Department of Haematology University College London Hospitals NHS Foundation Trust London United Kingdom.; Musto P; Department of Precision and Regenerative Medicine and Ionian Area 'Aldo Moro' University School of Medicine Bari Italy.; Hematology and Stem Cell Transplantation Unit AOU Consorziale Policlinico Bari Italy.; Rodriguez-Otero P; Cancer Center Clinica Universidad de Navarra CIMA, IDISNA, CIBERONC Pamplona Spain.; Yong K; Department of Haematology University College London Hospitals NHS Foundation Trust London United Kingdom.; Kortüm M; Department of Internal Medicine II University Hospital of Würzburg Würzburg Germany.; Rasche L; Department of Internal Medicine II University Hospital of Würzburg Würzburg Germany.; Terpos E; Department of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Athens Greece.; Raab MS; Heidelberg Myeloma Center, Department of Internal Medicine V Heidelberg University Hospital and Medical Faculty Heidelberg Germany.; Boccadoro M; Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy.; European Myeloma Network (EMN) Torino Italy.; Sonneveld P; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.; Einsele H; Department of Internal Medicine II University Hospital of Würzburg Würzburg Germany.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Editorial & Opinion
Puig N; Hematology Department IBSAL, Instituto de Biología Molecular y Celular del Cáncer-Consejo Superior de Investigaciones Científicas (IBMCC-CSIC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Salamanca Spain.; Agulló C; Clinical Biochemistry Department Hospital Universitario de Salamanca Salamanca Spain.; Paiva B; Clínica Universidad de Navarra, CUN, CIMA, IDISNA, CIBERONC CB16/12/00369 Pamplona Spain.; Cedena MT; Hospital Universitario 12 de Octubre, Complutense University, i + 12, CNIO, CIBERONC, CB16/12/00369 Madrid Spain.; Rosiñol L; Hospital Clinic, Institut d'Investigacions Biomédiques August Pi I Sunyer (IDIBAPS) Barcelona Spain.; Contreras T; Clinical Biochemistry Department Hospital Universitario de Salamanca Salamanca Spain.; Martínez-López J; Hospital Universitario 12 de Octubre, Complutense University, i + 12, CNIO, CIBERONC, CB16/12/00369 Madrid Spain.; Oriol A; Institut Català d'Oncologia, Institut Josep Carreras, Hospital Germans Trias I Pujol Barcelona Spain.; Blanchard MJ; Hematology Department Hospital Ramón y Cajal Madrid Spain.; Ríos-Tamayo R; Hospital Universitario Virgen de las Nievels, Ibs Granada Spain.; Sureda A; Institut Catalá d'Oncologia- l'Hospitalet, IDIBELL, Universitat de Barcelona Barcelona Spain.; Lakhwani S; Hospital Universitario de Canarias Santa Cruz de Tenerife Spain.; de la Rubia J; Hematology Department University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia, CIBERONC CD16/12/00284 Valencia Spain.; Cabañas V; Hospital Universitario Virgen de la Arrixaca, IMIB Murcia Spain.; de Arriba F; Hospital Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia Murcia Spain.; Paricio M; Hospital Clínico Universitario Lozano Blesa, Instituto Investigacion Sanitaria Aragon Zaragoza Spain.; Iñigo MB; Hospital Clínico San Carlos Madrid Spain.; González-Calle V; Hematology Department IBSAL, Instituto de Biología Molecular y Celular del Cáncer-Consejo Superior de Investigaciones Científicas (IBMCC-CSIC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Salamanca Spain.; Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria Santander Spain.; Castro S; Clinical Biochemistry Department Hospital Universitario de Salamanca Salamanca Spain.; Bargay J; Hospital Universitario Son Llàtzer, IdIsBa Palma de Mallorca Spain.; Bladé J; Hospital Clinic, Institut d'Investigacions Biomédiques August Pi I Sunyer (IDIBAPS) Barcelona Spain.; San Miguel JF; Clínica Universidad de Navarra, CUN, CIMA, IDISNA, CIBERONC CB16/12/00369 Pamplona Spain.; Lahuerta JJ; Hospital Universitario 12 de Octubre, Complutense University, i + 12, CNIO, CIBERONC, CB16/12/00369 Madrid Spain.; Mateos MV; Hematology Department IBSAL, Instituto de Biología Molecular y Celular del Cáncer-Consejo Superior de Investigaciones Científicas (IBMCC-CSIC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Salamanca Spain.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Zabaleta A; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain, Pamplona, Spain.; Tamariz-Amador LE; Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), CCUN, CIBER-ONC numbers CB16/12/00369, CB16/12/00489, Pamplona, Pamplona, Spain.; Kostopoulos IV; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Sklavenitis Pistofidis R; 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; 4Harvard Medical School, Boston, MA; 5Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Smits F; 6Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 7Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands; 8Department of Hematology, HagaZiekenhuis, The Hague, Netherlands, Netherlands.; Rodriguez-Otero P; Cancer Center Clínica Universidad de Navarra, Pamplona, Spain.; Roncal C; CIMA, Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, IdisNA, Pamplona, Spain.; Aranha MP; 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; 4Harvard Medical School, Boston, MA; 5Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Žihala D; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic, Czech Republic.; Machu M; University Hospital Brno and Faculty of Medicine, Masaryk University Brno, Brno, Czech Republic.; Tsakirakis N; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Bakouros P; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Tsitsilonis O; Department of Biology, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Solia I; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Moreno C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain, Spain.; Maia C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplon, Pamplona, Spain.; Martin-Sanchez E; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain, Spain.; Pérez JJ Sr; Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), CIBER-ONC number CB16/12/00233, Salamanca, Spain, Spain.; Encinas C; Hospital General Universitario Gregorio Marañón, liSGM, Madrid, Spain, Spain.; Ríos-Tamayo R; Hospital Universitario Virgen de las Nieves, Granada, Spain.; Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Badalona, Barcelona, Spain, Spain.; Blanchard MJ; Hospital Universitario Ramon y Cajal, Madrid, Spain.; de Arriba F; Hospital Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia, Murcia, Spain, Spain.; González-García E; Hospital Universitairo Cabueñes, Gijón, Spain, Spain.; Lakhwani S; Hospital Universitario de Canarias, Universidad de la Laguna, Santa Cruz de Tenerife, Spain, Spain.; Sureda A; Institut Català d'Oncologia and Institut Josep Carreras, Badalona, Barcelona, Spain, Spain.; Cabañas V; Department of Hematology, IMIB-Virgen de la Arrixaca University Hospital. University of Murcia, Murcia, Spain, Spain.; Escalante F; Complejo Hospitalario de León, León, Spain, Spain.; Carrillo-Cruz E; Virgen del Rocío University Hospital, Sevilla, Spain.; Pérez-Montaña A; Hospital Universitario Son Espases, Palma, Spain, Spain.; Ocio EMM; University Hospital Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander, Spain.; Bargay J; Hospital Universitario Son Llatzer, Institut d' investigacio Illes Balears (IdISBa), Palma de Mallorca, Spain, Spain.; Orfao A; Department of Medicine and Cytometry Service, Centro de Investigacion del Cancer (IBMCC, USAL-CSIC), University of Salamanca, CIBER-ONC CB16/12/00400, Salamanca, Spain, Spain, Spain.; Jelínek T; Department of Haematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic, Czech Republic.; Ghobrial IM; 3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; 4Harvard Medical School, Boston, MA; 5Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Mutis T; 6Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 7Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands, Netherlands.; Zweegman S; 6Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands; 7Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands, Netherlands.; Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Kastritis E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece, Greece.; Martínez-López J; Hospital Universitario 12 de Octubre, CIBER-ONC number CB16/12/00369, Madrid, Spain, Spain.; Lahuerta JJ; Hospital Universitario 12 de Octubre, CIBER-ONC number CB16/12/00369, Madrid, Spain, Spain.; Fernández de Larrea C; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain, Spain.; Rosiñol L; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain, Spain.; Bladé J; Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain, Spain.; Mateos MV; Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), CIBER-ONC number CB16/12/00233, Salamanca, Spain, Spain.; San-Miguel JF; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Spain.; Cedena MT; Hospital Universitario 12 de Octubre, Madrid, Spain.; Puig N; Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), CIBER-ONC number CB16/12/00233, Salamanca, Spain, Spain.; Paiva B; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC number CB16/12/00369, Pamplona, Spain, Spain.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Manubens A; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.; Paiva B; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.; Gutiérrez NC; Department of Hematology University Hospital of Salamanca, IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC Salamanca Spain.; Fernandez M; Instituto de Investigación Hospital Universitario 12 de Octubre Madrid Spain.; Calasanz MJ; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.; Rosiñol L; Hospital Clinic i Provincial de Barcelona, IDIBAPS Barcelona Spain.; Oriol A; Hospital Universitari Germans Trias i Pujol Badalona Spain.; Blanchard MJ; Hospital Ramón y Cajal Madrid Spain.; Carrillo E; Complejo Hospitalario Regional Virgen Del Rocío Sevilla Spain.; Benavente C; Hospital Clínico San Carlos Madrid Spain.; Martínez-López J; Instituto de Investigación Hospital Universitario 12 de Octubre Madrid Spain.; Bargay J; Hospital Universitario Son Llàtzer Palma de Mallorca Spain.; Hernández MT; Hospital Universitario De Canarias La Laguna Spain.; de la Rubia J; Hospital Universitario la Fe, Instituto de Investigación Sanitaria La Fe, School of Medicine and Dentistry Catholic University of Valencia Valencia Spain.; González Y; Hospital Universitari Dr. Josep Trueta de Girona Girona Spain.; Paricio M; Hospital Clínico Universitario Lozano Blesa Zaragoza Spain.; de Arriba F; Hospital General Universitario Morales Meseguer, IMIB-Pascual Parrilla. Universidad de Murcia Murcia Spain.; Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL) Universidad de Cantabria Santander Spain.; Teruel AI; Hospital Clínico Universitario de Valencia Valencia Spain.; de la Guia AL; Hospital Universitario La Paz Madrid Spain.; Sirvent M; Hospital Universitario de Donostia San Sebastián Spain.; Gironella M; Hospital Universitari Vall d'Hebron Barcelona Spain.; Sampol A; Hospital Universitario Son Espases Palma de Mallorca Spain.; Arguiñano JM; Hospital Universitario de Navarra Pamplona Spain.; Cabrera C; Hospital Universitario de Cáceres Cáceres Spain.; Alegre A; Hospital Universitario de La Princesa Madrid Spain.; Granell M; Hospital de la Santa Creu i Sant Pau Barcelona Spain.; Cabañas V; Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Pascual Parrilla University of Murcia Murcia Spain.; Núñez-Córdoba JM; Cancer Center Clínica Universidad de Navarra Pamplona Spain.; Mateos MV; Department of Hematology University Hospital of Salamanca, IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC Salamanca Spain.; Lahuerta JJ; Instituto de Investigación Hospital Universitario 12 de Octubre Madrid Spain.; San Miguel JF; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.; Bladé J; Hospital Clinic i Provincial de Barcelona, IDIBAPS Barcelona Spain.; Rodriguez-Otero P; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Martín-Sánchez E; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain. emartinsan@unav.es.; Tamariz-Amador LE; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Guerrero C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Zherniakova A; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Zabaleta A; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Maia C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Blanco L; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Alignani D; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Fortuño MA; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Grande C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Manubens A; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Arguiñano JM; Hospital Universitario de Navarra, IdiSNA, Pamplona, Spain.; Gomez C; Hospital Universitario de Galdakao, Galdakano, Spain.; Perez-Persona E; Hospital Universitario de Araba-Txagorritxu, Vitoria-Gasteiz, Spain.; Olazabal I; Hospital Universitario de Donostia, San Sebastian, Spain.; Oiartzabal I; Hospital Universitario de Cruces, Bilbao, Spain.; Panizo C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Hospital Universitario de Donostia, San Sebastian, Spain.; Prosper F; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; San-Miguel JF; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Rodriguez-Otero P; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Paiva B; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain. bpaiva@unav.es.
Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Academic Journal
Zabaleta A; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Puig N; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Cedena MT; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain.; Oliver-Caldes A; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Perez JJ; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Moreno C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Tamariz-Amador LE; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Rodriguez-Otero P; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Prosper F; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Gonzalez-Calle V; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; López-Corral L; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Rey-Búa B; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Puertas B; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Mirás F; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain.; Sánchez-Pina JM; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain.; López-Muñoz N; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain.; Juan M; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; González-Navarro EA; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Urbano Á; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; de Larrea CF; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Blade J; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Lahuerta JJ; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Martinez-Lopez J; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain.; Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; San Miguel JF; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Paiva B; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Academic Journal
González-Calle V; Department of Hematology, Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC) CIBERONC Salamanca Spain.; Rodriguez-Otero P; Department of Hematology, Cancer Center Clinica Universidad de Navarra, CCUN, Centro de Investigacion Medica Aplicadas (Cima); Instituto de Investigación Sanitaria de Navarra (IDISNA) CIBERONC Pamplona Spain.; Calasanz MJ; Department of Hematology, Cancer Center Clinica Universidad de Navarra, CCUN, Centro de Investigacion Medica Aplicadas (Cima); Instituto de Investigación Sanitaria de Navarra (IDISNA) CIBERONC Pamplona Spain.; Guijarro M; Department of Hematology, Hospital Universitario 12 de Octubre, I + 12, CNIO Complutense University, CIBERONC Madrid Spain.; Martínez-López J; Department of Hematology, Hospital Universitario 12 de Octubre, I + 12, CNIO Complutense University, CIBERONC Madrid Spain.; Rosiñol L; Department of Hematology, Hospital Clínic IDIBAPS Barcelona Spain.; Hernández MT; Department of Hematology Hospital Universitario de Canarias Tenerife Spain.; Teruel AI; Department of Hematology Hospital Clínico de Valencia Valencia Spain.; Gironella M; Department of Hematology Hospital Vall d'Hebron Barcelona Spain.; Oriol A; Department of Hematology, Institut Català d'Oncologia i Institut Josep Carreras Hospital Germans Trias i Pujol Badalona Spain.; de la Rubia J; Department of Hematology, Hospital Universitario y Politécnico La Fe CIBERONC Valencia Spain.; González-Rodríguez AP; Department of Hematology Hospital Universitario Central De Asturias Oviedo Spain.; Bargay J; Department of Hematology Hospital Son Llatzer Palma de Mallorca Spain.; de Arriba F; Department of Hematology, Hospital Morales Meseguer, IMIB-Pascual Parrilla Universidad de Murcia Murcia Spain.; Palomera L; Department of Hematology Hospital Clinico Universitario Lozano Blesa Zaragoza Spain.; González-Pérez MS; Department of Hematology, University Hospital of Santiago de Compostela Servizo Galego de Saúde (SERGAS) Santiago de Compostela Spain.; Sureda A; Department of Hematology Institut Català D'Oncologia L'Hospitalet Badalona Spain.; Ocio E; Department of Hematology Hospital Universitario Marques de Valdecilla Santander Spain.; Lahuerta JJ; Department of Hematology, Hospital Universitario 12 de Octubre, I + 12, CNIO Complutense University, CIBERONC Madrid Spain.; Bladé J; Department of Hematology, Hospital Clínic IDIBAPS Barcelona Spain.; San Miguel JF; Department of Hematology, Cancer Center Clinica Universidad de Navarra, CCUN, Centro de Investigacion Medica Aplicadas (Cima); Instituto de Investigación Sanitaria de Navarra (IDISNA) CIBERONC Pamplona Spain.; Mateos MV; Department of Hematology, Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC) CIBERONC Salamanca Spain.; Gutiérrez NC; Department of Hematology, Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC) CIBERONC Salamanca Spain.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Lasa M; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBERONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Gonzalez C; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBERONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Notarfranchi L; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBERONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Zherniakova A; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBERONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Russian Research Institute of Hematology and Transfusiology, St Petersburg, Russia.; Alignani D; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBERONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Burgos L; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBERONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Calasanz MJ; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBERONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Rodriguez-Otero P; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBERONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Perez JJ; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, University of Salamanca, CIBERONC CB16/12/00233, Salamanca, Spain.; Gomez C; Hospital de Galdakao, Vizcaya, Spain.; Gonzalez de la Calle V; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, University of Salamanca, CIBERONC CB16/12/00233, Salamanca, Spain.; de Arriba F; Hospital Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia, Murcia, Spain.; Palomera L; Instituto de Investigacion Sanitaria Aragon, Hospital Clinico Universitario Lozano Blesa, Zaragoza, Spain.; Alvarez Rivas MA; Hospital Universitario Reina Sofia, Cordoba, Spain.; Clavero E; Hospital Universitario Virgen De Las Nieves, Granada, Spain.; Ocio EM; Hospital Universitario Marques de Valdecilla (IDIVAL), Universidad de Cantabria, Santander, Spain.; Gonzalez-Rodriguez AP; Hospital Universitario Central de Asturias, Oviedo, Spain.; Lakhwani S; Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.; Ibañez A; Complejo Hospitalario Universitario de Albacete, Albacete, Spain.; Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain.; Sureda A; Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain.; Rosiñol L; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain.; Siewert C; Research and Development, Miltenyi Biotec BV & Co KG, Bergisch Gladbach, Germany.; Orfao A; Department of Medicine and Cytometry Service, Centro de Investigacion del Cancer (IBMCC, USAL-CSIC), University of Salamanca, CIBERONC CB16/12/00400, Salamanca, Spain.; Lahuerta JJ; Hospital Universitario 12 de Octubre, University Complutense, CIBERONC CB16/12/00369, CNIO, Madrid, Spain.; Blade J; Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain.; Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, University of Salamanca, CIBERONC CB16/12/00233, Salamanca, Spain.; San-Miguel JF; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBERONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Cedena MT; Hospital Universitario 12 de Octubre, University Complutense, CIBERONC CB16/12/00369, CNIO, Madrid, Spain.; Martinez-Lopez J; Hospital Universitario 12 de Octubre, University Complutense, CIBERONC CB16/12/00369, CNIO, Madrid, Spain.; Puig N; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, University of Salamanca, CIBERONC CB16/12/00233, Salamanca, Spain.; Paiva B; Cancer Center Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra, CIBERONC CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Conference
Clinical Lymphoma Myeloma & Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
instname
검색 결과 제한하기
제한된 항목
[검색어] Miguel, JF San
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어